目的：从人脐血单个核细胞(CBMC)中高效扩增CD 56 +细胞毒性淋巴细胞。
Objective: to expand CD56 + cytotoxic lymphocytes from human umbilical cord blood mononuclear cells (CBMC).
白细胞介素-12（IL-12）最初称作自然杀伤细胞刺激因子（NKSF）或细胞毒性淋巴细胞成熟因子（CLMF），是一种异二聚体细胞因子。
Interleukin-12 (IL-12) previously called cytotoxic lymphocyte maturation factor (CLMF) or NK cell stimulatory factor (NKSF) is a recently characterized heterodimeric cytokine composed of two subunits.
并且测定了样品对T、B淋巴细胞的免疫活性和细胞毒性。
The immunocompetence and cell toxicity of the samples toward Tand B lymphocyte were determined.
目的研究MAGE-A3抗原肽负载对乳腺癌患者树突状细胞（DC）的功能的影响，探讨其是否可以在体外诱导特异性细胞毒性T淋巴细胞（CTL）应答。
Objectve: To investigate whether the dendritic cells(DCs) loaded with the peptide derived from MAGE-A3 could induce specific cytotoxic T lymphocytes(CTLs) response in breast cancer patients in vitro.
药物及病毒再激活引发的免疫过敏反应所致组织损害主要南cd 8 +细胞毒性T淋巴细胞造成。
The drug and virus reactivation destroy tissues by an immune allergic reaction. And the destruction is primarily caused by CD8 + cytotoxic t lymphocytes.
实验发现来源于肿瘤组织的淋巴细胞群(TIL)对自体肿瘤无自然杀伤细胞活性或仅有低效细胞毒性。
The tumor-derived lymphocytes population (TIL) were of no natural killing activity or low cytotoxicity against the autologouS tumors.
并结合细胞毒性T淋巴细胞(CTL)试验了解宿主脾细胞中T细胞亚群的动态改变。
Successive changes of subgroups of t cells in spleen cells were studied by cell toxic lymphocyte (CTL) test.
用乳酸脱氢酶(LDH)释放法测定小鼠细胞毒性T淋巴细胞反应。
The cytotoxic t lymphocyte response was determined by LDH release method.
目的探讨白细胞介素（IL）2与IL4对膀胱癌肿瘤浸润性淋巴细胞（TIL）体外增殖及细胞毒性免疫调控的协同作用。
Objective To investigate the synergy effects of IL 2 and IL 4 on the proliferation and cytotoxicity of tumor infiltrating lymphocytes (TIL) from murine bladder carcinoma in vitro.
目的观察大鼠体外脾淋巴细胞经不同压力—时程的高分压氧处理后淋巴细胞增殖及细胞毒性T淋巴细胞（CTL）杀伤能力的变化。
Objective To observe the effects of hyperbaric oxygen on the proliferation rate and total cytotoxicity T lymphocyte(CTL) activity of rat splenic lymphocytes.
目的：探讨负载肿瘤抗原的树突状细胞(DC)疫苗诱导的细胞毒性T淋巴细胞(CTL)的体外杀瘤作用及对荷瘤小鼠的治疗作用。
Objective: to explore the anti-tumor effects of cytotoxic of T-lymphocytes (CTL) induced by dendritic cells (DC) vaccine loaded with tumor antigen.
除了显著的特异抗体应答外，本发明的制剂能够产生强的淋巴增殖性应答和细胞毒性T淋巴细胞。
The aforementioned formulations can generate a strong lymphoproliferative response and cytotoxic t lymphocytes, as well as a significant specific antibody response.
用积液相关淋巴细胞中细胞毒性T淋巴细胞来研究肿瘤导致的免疫抑制状态切实可行。
It is practicable to use Cytotoxic t Lymphocyte of Effusion-Associated Lymphocytes for studying tumor-induced immunosuppression.
用积液相关淋巴细胞中细胞毒性T淋巴细胞来研究肿瘤导致的免疫抑制状态切实可行。
It is practicable to use Cytotoxic t Lymphocyte of Effusion-Associated Lymphocytes for studying tumor-induced immunosuppression.
应用推荐